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Gene Doping: The Game Changing Technological Advancement of the Next 
Generation 
 
I. Introduction 
 To many Americans, sports enthusiasts, and cancer patients, Lance Armstrong’s 
confession to Oprah Winfrey on January 17
th
, 2013 was both shocking and game 
changing 
1
. Many lost their golden boy who had won seven Tours de France, some lost 
respect for the sport that had claimed to be clean time and again, and others lost hope that 
they too could survive cancer just like Lance and come back stronger than ever 
2. Lance’s 
confession, however, is game changing on different levels (i.e. anti doping measures, 
professional sports' credibility, sponsorship fallout) now that sporting organizations and 
anti-doping agencies have been completely embarrassed by the fact that athletes like 
Lance have been able to beat their tests for so long 
3
. In the cycling world alone, even 
long-time Dutch sponsor Rabobank (1996-2012) pulled out, leaving its team named 
                                                        
1
 Oprah Winfrey, Lance Armstrong Talks to Oprah, OWN (last visited May 14, 2013), 
http://www.oprah.com/own_tv/onc/lance-armstrong-one.html. 
2
 Steve Almasy, Cycling, Facing An Uphill Climb, Hopes Next Hero Just Around Bend, 
CNN, (last visited May 14, 2013), http://www.cnn.com/2013/01/18/sport/cycling-
future/index.html?hpt=hp_c3. 
3
 David Walsh, UCI Embarrassed by Lance Armstrong Report, RTE NEWS (last visited 
May 14, 2013), http://www.rte.ie/news/player/2012/1022/3420156-uci-embarrassed-by-
lance-armstrong-report-the-sunday-times-chief-sports-writer-david-walsh/. 
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"Blanco" for lack of a title sponsor 
4
.  Further, the International Cycling Union (UCI) is 
taking extra precautions for this summer's Tour de France by cooperating with two 
independent agencies it has bumped heads with in the past; the Cycling Anti-Doping 
Foundation (CADF) and the French Anti-Doping Agency (AFLD) 
5
. Whether the 2013 
Tour de France is won clean will remain to be scene, and after cancelling the results from 
1999-2005 (the Lance years) its credibility depends on it 
6
. 
 While cycling and other sports might go through a period of clean competition as 
a reaction to the Armstrong scandal, inevitably athletes seeking a competitive edge will 
find new methods of beating the tests. “Gene doping,” or the use of gene therapy 
techniques to increase the production of performance-enhancing proteins, might just be 
the next big thing 
7
! Also, given the financial incentives of winning a Tour de France, 
World Series, or Superbowl, the athletic field might just be the first place where genetic 
modification is implemented. As each new method of enhancing performance is released, 
the ever slow-to-catch-up anti-doping controls seem more and more a futile exercise.  
 Authorities such as the World Anti Doping Agency (WADA) and the U.S. Anti 
Doping Agency (USADA) will have to devise a way to regulate the future of gene 
doping. How they develop such a method will be interesting to see in coming years since 
there is neither a test, nor a human trial authorities can point to as a guinea pig. One such 
                                                        
4
 Rabobank Ends Sponsorship of Professional Cycling Team, BBC (last visited May 14, 
2013), http://www.bbc.co.uk/sport/0/cycling/20001685. 
5
 Yuzuru Sunada, UCI and AFLD to Cooperate at Tour, PELOTON (last visited May 14, 
2013), http://www.pelotonmagazine.com/Feedzone/content/6/2267/UCI-and-AFLD-to-
Cooperate-at-Tour. 
6
 Graham Dunbar, Lance Armstrong Stripped of His 7 Tour de France Titles, WLTV (last 
visited May 14, 2013), http://www.wwltv.com/sports/UCI-agrees-to-stripping-
Armstrong-of-Tour-de-France-medals-175217311.html. 
7
 MICHAEL J. SANDEL, THE CASE AGAINST PERFECTION: ETHICS IN THE AGE OF GENETIC 
ENGINEERING 45-62 (Belknap Press, 1st ed. 2009).  
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method would be to completely ban gene doping from competition such as performance-
enhancing pharmaceutical substances, while another would be to treat it as a permissible 
technological innovation such as the prosthetic legs used by the “Blade Runner,” Oscar 
Pistorius 
8
. The mere fact that WADA has already labeled the practice "gene doping" is 
indicative of how they intend to treat it. Still, they have jumped the gun and failed to 
make an objective decision on a currently experimental procedure. 
 This paper will explore the world of gene doping and its intersection with law in 
athletics. First, I will provide an overview of gene doping before diving into the legal and 
moral framework of doping in athletics. Here, I will argue that gene doping does not fit 
within the present framework of prohibiting performance-enhancing drugs and 
techniques. The very nature of gene doping will require anti-doping agencies to take a 
fresh look and take a new approach to regulate gene doping's "gray" areas. Finally, I will 
propose that sporting bodies adopt a framework to allow genetically enhanced athletes to 
compete side-by-side with natural athletes, or alternatively, in a league of their own so 
that some level of fairness and safety is preserved while also letting all athletes compete, 
natural or genetically enhanced.  
 
II. What Exactly is Gene Doping? 
 The basic premise behind gene doping is introducing a desired gene into the 
athlete’s body, which will incorporate into his or her cells and be expressed as a natural 
                                                        
8
 "Blade Runner's" Artificial Legs Controversial at Olympics, CBS NEWS (last visited 
May 14, 2013), http://www.cbsnews.com/video/watch/?id=7416890n. 
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gene 
9
. For example, if a person wanted to run faster and can pinpoint a number of genes 
that can make them do so, that person would incorporate those genes into their genome 
and genetically modify him or herself to run faster. Two potential forms of gene doping 
are: somatic cell modification in which genes are modified in a bodily cell like a muscle 
or lung, and germline modification in which a sperm, egg, or embryo is genetically 
modified, meaning the enhancements pass from one generation to another 
10
. The focus 
of this paper is on somatic cell modification since athletes are more likely to gene dope 
themselves, though the possibility of parents breeding enhanced athletes certainly exists 
11
. There are currently over a thousand gene therapy trials that are looking for ways to 
cure diseases, and it is thought that the same techniques employed in these trials would be 
used to introduce performance-enhancing genes into the athlete’s body 12. The three 
methods that could introduce artificial genes into an athlete’s body are: loading those 
genes onto a virus that is introduced into the body, cultured cells that are modified and 
introduced into the body, and injecting foreign DNA into the athlete’s muscle or 
bloodstream 
13
. Each method is described more thoroughly below. 
 
                                                        
9
 Susan L. Nasr, How Gene Doping Works, HOW STUFF WORKS (last visited May 14, 
2013), http://science.howstuffworks.com/life/genetic/gene-doping.htm. 
10
 Kathi E. Hanna, Germline Gene Transfer, NATIONAL HUMAN GENOME RESEARCH 
INSTITUTE (last visited May 14, 2013), http://www.genome.gov/10004764; Nasr supra 
note 9.  
11
 Susannah Baruch, Human Germline Genetic Modification: Issues and Options for 
Policymakers, GENETICS AND PUBLIC POLICY CENTER, 
http://www.dnapolicy.org/images/reportpdfs/HumanGermlineGeneticMod.pdf; Hanna 
supra note 10. 
12
 ANGELA J. SCHNEIDER & THEODORE FRIEDMAN, GENE DOPING IN SPORTS: THE SCIENCE 
AND ETHICS OF GENETICALLY MODIFIED ATHLETES 30 (Academic Press, 1st ed. 2006).  
13
 Mehmet Unal & Durisehvar Ozer Unal, Gene Doping in Sports, 34 SPORTS MED. 357, 
358 (2004).  
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 A. Methods of Delivery 
 Virus Loading: T. Beiter of the University of Tubigen, Department of Sports 
Medicine, explained how a virus would first be needed to provide a means of delivering 
the genetic material in the body 
14
. Before infecting the subject, the virus is modified or 
loaded with a "cassette" of DNA 
15
. The virus, once in the body, delivers the cassette of 
genetic material into the cells, forming a blueprint of whatever proteins expression is 
desired 
16
. Viruses have the most capacity to carry genetic material, and are thought to be 
the preferred method of gene doping 
17
. 
 Modified Cells: M.B. Rosenberg of the University of California School of 
Medicine, Department of Pediatrics explained how fibroblasts were genetically modified 
to secrete nerve growth factor (NGF) by infection with a retro virus before implanting the 
fibroblast into mice with surgical lesions 
18
. The grafted cells were successful and 
produced enough NGF to stop degeneration of neurons, which would die if left untreated 
19
.  
                                                        
14
 Thomas Beiter et al., Establishing A Novel Single-Copy Primer-Internal Intron 
Spanning PCR (spiPCR) Procedure For The Direct Detection Of Gene Doping, 14 
EXERC IMMUNOL REV. 73-85 (2008). 
15
 Alexis C. Madrigal, By the Next Olympics, Athletes May Be Getting Routine Gene 
Doping Tests, THE ATLANTIC (last visited May 14, 2013), 
http://www.theatlantic.com/technology/archive/2012/08/by-the-next-olympics-athletes-
may-be-getting-routine-gene-doping-tests/260700/. 
16
 Id. 
17
 Christie Aschwaden, Gene Cheats, NEW SCIENTIST (last visited May 14, 2013), 
http://www.archway.ac.uk/Activities/Departments/SHHP/downloads/epo/Genecheats/gen
echeats.html. 
18
 M.B. Rosenberg et al, Grafting Genetically Modified Cells to the Damaged Brain: 
Restorative Effects of NGF Expression, SCIENCE, 
http://www.sciencemag.org/content/242/4885/1575.full.pdf. 
19
 Id. 
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 Foreign DNA Injection: I. Danko of the University of Wisconsin-Madison, 
Department of Pediatrics explained his method of injecting foreign DNA in mice, dogs, 
and monkeys 
20
. He injected DNA over a 1-minute period using a 1ml syringe and 27-
gauge needle 
21
. He explains that the animals' muscles were directly exposed to facilitate 
injection into specific muscle groups and the incisions were later closed 
22
. The use of 
naked DNA plasmids yielded the highest expression two weeks after the procedure 
23
. 
This procedure looks the most similar to pharmaceutical doping, and would likely be the 
least popular for its invasiveness. 
 
B. Target Genes and Possibilities 
 There are several genes with different potential advantages for athletes interested 
in gene doping: Erythropoietin (EPO) for endurance, Insulin-like Growth Factor-1 (IGF-
1) and Myostatin for strength, Vascular Endothelial Growth Factor (VEGF) for increased 
blood flow, and Leptin for weight loss 
24
. Two of these are common in pharmaceutical 
doping and would be immensely popular in gene doping: the introduction of EPO in 
endurance athletes, and IGF-1 in power athletes 
25
. The others would likely be 
supplementary, used to further enhance the effects of EPO and IGF-1.  
                                                        
20
 I. Danko et al, High Expression of Naked Plasmid DNA in Muscles of Young Rodents, 
HUMAN MOLECULAR GENETICS, http://hmg.oxfordjournals.org/content/6/9/1435.full.pdf. 
21
 Id. 
22
 Id. 
23
 Id. 
24
 Unal & Unal, supra note 13, at 358. 
25
 Edward H. Jurith & Mark W. Beddoes, The United States’ and International Response 
to the Problem of Doping in Sports, 12 FORDHAM INTELLECTUAL PROPERTY, MEDIA, & 
ENTERTAINMENT L.J. 461, 470 (2002).  
 Popstefanov 7 
 EPO has long been used in sports such as cycling and running because it is a 
hormone produced by the kidney that increases the number of red blood cells in the body, 
which help the athlete absorb more oxygen and thus, augment his or her aerobic capacity 
26. EPO’s synthetic version, Epoetin Alfa, is commonly used to treat forms of cancer and 
kidney diseases, while also used illegally by athletes looking to increase their endurance 
in competition 
27
. Ex vivo EPO gene transfers have already been successfully introduced 
into mice, triggering increased red blood cell counts 
28
. If this method were one day 
introduced to humans, the results would be both positive and negative. On the one hand it 
would be another, perhaps, more effective method of treating diseases and cancers, while 
on the other hand it would be another way for athletes to cheat their competition. For 
athletes, EPO gene transfers mean they can stimulate the kidney to produce more 
"natural" (now that it has incorporated in the human genome) EPO, which increases red 
blood cells, raises hematocrit levels, and permanently boost their performance. 
 Likewise, IGF-1 has been successfully introduced into mice via in vivo gene 
transfers, which increased muscle growth 
29
. This form of gene transfer would be popular 
among baseball, basketball, and football players as it could be injected directly into the 
muscles they wish to grow, producing localized results. Through this method, athletes 
could target what it is they need to improve, whether it is jumping higher, throwing 
                                                        
26
 I. Casoni et al, Hematological Indices of Erythropoietin Administration in Athletes, 
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 
https://profile.thieme.de/HTML/sso/ejournals/login.htm?type=default&subsidiary=www.
thieme-connect.com&hook_url=https%3A%2F%2Fwww.thieme-
connect.com%2Fejournals%2Fpdf%2F10.1055%2Fs-2007-1021183.pdf. 
27
 SCHNEIDER & FRIEDMANN, supra note 12, at 44.  
28
 Id. at 44-45.  
29
 Melinda Wenner, How to Be Popular During the Olympics: Be H. Lee Sweeney, Gene 
Doping Expert, SCIENTIFIC AMERICAN, (last visited May 14, 2013), 
http://www.scientificamerican.com/article.cfm?id=olympics-gene-doping-expert. 
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faster, or hitting harder without spending countless hours in the gym. Though IGF-1 is 
banned by anti-doping bodies, it is widely available on the Internet in various forms of 
"Deer Antler Spray" 
30
. Several collegiate and professional football players have been 
linked to the substance in recent years, spurring cease-and-desist letters to break the line 
of communication between manufacturers and athletes 
31
. The genetic introduction of 
IFG-1 into human athletes means they can produce more power and avoid current forms 
of detection since the procedure would only need to be done once instead of periodically. 
 Similarly, proteins such as Myostatin would take the place of clenbuterol, which 
has been used to treat asthma as well as help athletes cut fat and increase muscle 
32
. 
Schneider and Friedmann have commented that by adjusting the metabolism of particular 
muscles in mice they were able to increase “slow-twitch” muscle fibers via the 
peroxisome proliferator-activated receptor (PPAR) delta gene allowing those mice to 
increase their endurance by reducing fat and functioning more efficiently 
33
. What this 
means for human athletes is that they can tailor their muscle fibers to better meet the 
demands of their sport. The two extremes are endurance (i.e. marathon runner) and power 
(i.e. 100 meter sprinter) and modifying one's fast or slow twitch fibers can make one run 
longer or sprint faster. 
 
 
                                                        
30
 Jerry Hinnen, S.W.A.T.S. Salesman Says He Watched Tide Players Use Deer Spray, 
CBS SPORTS, (last visited May 14, 2013), 
http://www.cbssports.com/collegefootball/blog/eye-on-college-football/21623944/swats-
salesman-says-he-watched-tide-players-use-deer-spray. 
31
 Id. 
32
 Wenner, supra note 29, at 12.  
33
 SCHNEIDER & FRIEDMANN, supra note 12, at 46.  
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C. Advantages of Gene Doping: Permanence and Lack of Detectability 
 There are at least two reasons why gene doping would be preferable to 
pharmaceutical doping to the athlete seeking an edge. Genetic modification is permanent, 
thus, once the foreign genes are introduced into the athlete, they become his or her own 
genetic material 
34
. By making doping a one-shot process, the cheating athlete would 
likely save money over the long-term, but more importantly eliminate the chance of 
getting caught by not having to periodically reintroduce a pharmaceutical drug 
35
. Just 
think how much more discrete a doper would be if every time he raised his arms in 
victory at the finish line or the podium, there would be no signs of needle injections on 
his arms (See 
https://securecdn.disqus.com/uploads/mediaembed/images/437/1408/original.jpg).  
 Similar to the reason above, gene doping is virtually undetectable because 
engineered genes produce proteins that look identical to naturally-occurring ones 
36
. 
Further, certain gene doping methods would not be detectable by blood tests, as they 
would be entirely contained in the muscle and not circulate in the blood at all 
37
. 
Extremely invasive muscle biopsies would be the only means of detection, however, few 
athletes would submit to slicing their muscles for such a test 
38
. Though tests are 
developing, there are no official gene doping tests as of now, making the practice 
invisible. 
                                                        
34
 Kristen Jo Custer, From Mice to Men: Genetic Doping in International Sports. 30 
HASTINGS INTERNATIONAL & COMPARATIVE L. REV. 181, 188 (2007). 
35
 Id.  
36
 Aschwaden, supra note 17.  
37
 Wenner, supra note 29, at 13.  
38
 Custer, supra note 24, at 203.  
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 Less invasive methods would be monitoring the athlete’s deoxyribonucleic acid 
(DNA) to detect changes and foreign DNA based on an initial base line DNA test, 
looking for the presence of virus vectors, and using imaging to detect artificial genes 
39
. 
These methods, however, are currently impractical and not reliable enough to use for 
competition 
40
. Likely alternatives would be to monitor for indirect evidence of gene 
doping such as changing focus to the proteins such genes would produce. While this 
method would not catch instances where muscles have been genetically enhanced and 
produce no byproduct in the bloodstream, it could be effective at detecting EPO since 
abnormal levels of hematocrit would be present in the bloodstream 
41
.  
 The current method for detecting EPO in athletes involves a “biological passport” 
which keeps track of the athletes hematocrit levels overtime after an initial baseline test 
42
. If a suspicious spike is detected, then sporting organizations have grounds to ban an 
athlete based on indirect evidence of hematocrit levels 
43. This method’s effectiveness 
would be limited in the context of gene doping because an athlete who has gene doped 
before his or her baseline test would continue to have an artificially high hematocrit level 
due to the procedure’s permanency. Similarly, athletes with a natural genetic mutation, 
such as Finnish cross-country skier Eero Mantyranta, would be labeled cheats for 
naturally producing hematocrit levels beyond the normal threshold 
44
.  Further, athletes 
                                                        
39
 Wenner, supra note 29, at 13. 
40
 Id.  
41
 Jurith & Beddoes, supra note 25, at 470. 
42
 Unal & Unal, supra note 13, at 360. 
43
 The Future of Cheating: EPO Gene Doping, CYCLING TIPS, (last visited May 14, 
2013), http://www.cyclingtips.com.au/2013/02/the-future-of-blood-doping-epo-gene-
doping/. 
44
 David T. Martin et al, Blood Testing for Professional Cyclists: What's a Fair 
Hematocrit Limit?, SPORTSCIENCE NEWS (last visited May 14, 2013), 
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with a legitimate  baseline test might opt to elevate their hematocrit levels over time, by 
modifying their EPO expression incrementally, as to not produce sudden spikes that are 
indicative of doping prior to competition. Still, this method is potentially dangerous since 
it is purely based on indirect evidence and would vilify athletes such as Eero Mantyranta, 
who was born with unusually high hematocrit levels as a result of a natural genetic 
mutation 
45
. 
 
 D. Risks, Uncertainties, and Other Considerations 
 As of now, it is hard to tell what exactly the risks of gene doping are since there 
are no known cases of gene doping that have surfaced, and genetic modification has only 
been used in a clinical context 
46
. In 1999, Jesse Gelsinger died shortly after a gene 
therapy clinical trial 
47
. Even though his rare liver disease was not life threatening, the 
immune response his body had proved the procedure to be fatal and halted gene therapy 
trials in the U.S. for some time after 
48
. 
 It is thought that EPO gene doping would carry the same risks as pharmaceutical 
EPO, such as circulatory abnormalities that can cause internal bleeding and death 
49
. 
Vascular Endothelial Growth Factor (VEGF) is thought to influence the expression of 
more than 200 genes, many of which are not well understood yet and have the potential 
                                                                                                                                                                     
http://www.sportsci.org/news/news9703/AISblood.html; Eero Mantyranta, SPORTS 
REFERENCE (last visited May 14, 2013), http://www.sports-
reference.com/olympics/athletes/ma/eero-mantyranta-1.html. 
45
 Aschwanden, supra note 17, at 29. 
46
 Challenges in Gene Therapy, GENETIC SCIENCE LEARNING CENTER (last visited May 
14, 2013), http://learn.genetics.utah.edu/content/tech/genetherapy/gtchallenges/. 
47
 Id. 
48
 Id. 
49
 CYCLING TIPS, supra note 43. 
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for serious complications 
50
. Since the rate of expression varies from one individual to 
another, genetic modification is still far from a precise science 
51
. There is a high 
probability that if the bloodstream is oversaturated with red blood cells, it would become 
too thick for the heart to pump 
52
.  
 Just recently, WADA announced that it would hold a meeting in China to review 
the progress of developing tests for gene doping, with hopes that they will be available by 
the next Olympics 
53
. Under review are two tests that WADA described as major 
breakthroughs: a blood test detecting gene doping as far back as 56 days, and another test 
for detecting gene doping in muscles 
54
. WADA says it has the scientific basis to detect 
gene doping, but that the methods would have to be developed in order to make the tests 
effective in real-world scenarios 
55
. This method is crucial as WADA was embarrassed 
that Lance Armstrong was able to beat over 500 doping tests in his career 
56
. The pressure 
is also on for WADA because scientists working on potential genetics cures have been 
contacted about genetic techniques to enhance performance 
57
. Without the proper 
                                                        
50
 Id. 
51
 Hanna, supra note 10. 
52
 Leslie Johns, 5 Things You Need To Know About Having Too Many Red Blood Cells, 
LIVESTRONG (last visited May 14, 2013), http://www.livestrong.com/article/5987-need-
having-many-red-blood/. 
53
 Stephen Wilson, WADA to Hold Meeting in China on Gene Doping, ABC NEWS (last 
visited May 14, 2013), http://abcnews.go.com/Sports/wireStory/wada-hold-meeting-
china-gene-doping-19098995#.UZJvXZUo1zs. 
54
 Id. 
55
 Id. 
56
 Brendan Gallagher, Lance Armstrong was Tipped Off 20 Minutes Before he was 
Tested, Claims French Anti-Doping Official, THE TELEGRAPH (last visited May 14, 2013), 
http://www.telegraph.co.uk/sport/othersports/cycling/lancearmstrong/9499744/Lance-
Armstrong-was-tipped-off-20-minutes-before-he-was-tested-claims-French-anti-doping-
official.html. 
57
 Wilson, supra note 53.  
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methods of administering potential doping tests, athletes will all too easily think of ways 
to beat them.  
 As mentioned above, somatic gene transfer only affects the athlete's body, yet 
germline transfer would affect the human genome, meaning the changes would be passed 
on to the offspring 
58
. Currently, there are no (known) germline clinical trials as its ethical 
value and desirability are being debated, however, somatic transfers can inadvertently 
lead to germline transfers since the methods of delivery can be hit-or-miss 
59
. Thus, 
genetic therapy is at such an early stage that there are many uncertainties, and the 
potential to unbalance genetic expression, alter or mutate the genome, and affect 
offspring is very real 
60
. Perhaps the only certainty is that unscrupulous athletes will forgo 
these risks to gain a competitive edge 
61
. 
 
III. Legal and Moral Framework of Doping in Athletics 
 In the past two decades a number of doping scandals have pressured international 
doping agencies to become more harmonized and effective at combating performance-
enhancing drugs 
62
. In 1999 the International Olympic Committee (IOC) called on the 
International Sports Federations and National Olympic Committees to meet in Lausanne, 
                                                        
58
 Hanna, supra note 10. 
59
 Id. 
60
 John Naish, Genetically Modified Athletes: Forget Drugs. There are Even Suggestions 
Some Chinese Athletes' Genes are Altered to Make Them Stronger, MAIL ONLINE (last 
visited May 14, 2013), http://www.dailymail.co.uk/news/article-2181873/Genetically-
modified-athletes-Forget-drugs-There-suggestions-Chinese-athletes-genes-altered-make-
stronger.html. 
61
 Id. 
62
 ANDY MIAH, GENETICALLY MODIFIED ATHLETES: BIOMEDICAL ETHICS, GENE DOPING 
AND SPORT 33 (Routledge, 1st ed. 2004).  
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Switzerland for the World Conference on Doping in Sport 
63
. The result was the 
establishment of the World Anti Doping Agency (WADA), which was created with two 
overriding principles: promoting fair play and protecting athletes’ health 64. As part of its 
mission WADA continually updates the World Anti-Doping Code, which lists all banned 
PEDs (anabolic steroids, amphetamine, EPO) and methods (blood doping and gene 
doping) that athletes are required to abide by 
65
. Likewise, individual countries have their 
own anti-doping bodies, such as the U.S. Anti Doping Agency (USADA), to help 
implement and administer WADA’s goals 66. 
 Within these anti-doping bodies, a discussion over gene doping has ensued for the 
past decade, recognizing that it will be confronted in the future 
67
. While WADA and 
others have often been criticized for responding slowly, they took full advantage of this 
opportunity to put in place a policy prior to the development of gene-doped athletes 
68
. As 
early as 2001 the IOC formed a group to address the future of gene doping in which they 
found that genetic modification could be medically sound, yet should be kept out of 
sports 
69
. The IOC Gene Therapy Working Group concluded,  
 
                                                        
63
 Custer, supra note 34, at 191.  
64
 WADA History, WORLD ANTI-DOPING AGENCY (last visited May 14, 2013), 
http://www.wada-ama.org/en/About-WADA/History/WADA-History/. 
65
 World Anti-Doping Code, WORLD ANTI-DOPING AGENCY (last visited May 14, 2013), 
http://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-
Organizations/The-Code/. 
66
 About USADA, US ANTI-DOPING AGENCY (last visited May 14, 2013), 
http://www.usada.org/about. 
67
 WADA, Special Feature: Gene Doping, 1 PLAY TRUE at 12, http://www.wada-
ama.org/Documents/Resources/Publications/PlayTrue_Magazine/PlayTrue_2005_1_Gen
e_Doping_EN.pdf.  
68
 MIAH, supra note 62, at 38. 
69
 Id. at 12. 
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"we are aware there is potential for abuse of gene therapy 
medicines and we shall begin to establish procedures and 
state-of-the-art testing methods for identifying athletes who 
might misuse such technology" 
70
.  
 
Since then doping investigations have shown how urgent this issue is, revealing evidence 
of running coach Thomas Springstein referencing Repoxygen in an email 
71
. Repoxygen 
is a form of EPO used in conjunction with gene therapy for anemic patients and would 
increase red blood cell production in enhanced athletes 
72
. 
 The next step taken against gene doping was WADA’s Banbury Conference in 
which its President, Richard Pound, explained that gene doping would make the realm of 
pharmaceutical doping look like the dark ages 
73
. In his push to speed the development of 
an anti gene-doping framework, two ideas emerged. The conference called for a gene 
doping detection program backed with numerous grants in the areas of genomics, 
proteomics, metabolomics, bioinformatics, and viral detection oriented at researching 
detection methods, as well as including gene doping within the World Anti-Doping Code 
74
. The addition of an anti gene-doping clause in the Code reflects the majority stance of 
anti-doping organizations that genetic modification is to be strictly banned from sports 
75
. 
WADA’s Pound has said that gene doping is a “slippery slope we do not ever want to go 
                                                        
70
 International Olympic Committee, Gene Therapy Working Group - Conclusions, IOC 
(last visited May 14, 2013), http://www.olympic.org/content/news/media-
resources/manual-news/1999-2009/2001/06/06/ioc-gene-therapy-working-group---
conclusions/. 
71
 Custer, supra note 34, at 20. 
72
 Id. 
73
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down” 76. The labeling of genetic modification as a form of “doping” was a significant 
step in banning it, as it makes clear the negative connotation associated with it 
77
. Pound 
has stated that WADA will fight gene doping just as vigorously as pharmaceutical doping 
since he and his colleges believe sports will not benefit from gene doped athletes, and it 
is critical to prevent such practices before they become widespread 
78
. 
 WADA’s justifications for banning genetic modification from sports are currently 
legitimate, as clinical studies have shown to have deadly side effects 
79
. Further, since 
genetic doping is a permanent modification of the body there is a danger that if the 
foreign gene produces too much of its protein product, there is no way to reduce or stop it 
80
. Another concern is that the interaction of the foreign gene with the native genes might 
have an unbalancing effect on the body resulting in a condition called pleiotropy, in 
which the foreign gene that was intended to boost EPO might accidently effect a 
completely unrelated gene and cause damage to the body 
81
. Finally, gene doping that 
targets specific muscles, such as IGF-1, would only strengthen the targeted muscles 
without strengthening their adjoining tendons and ligaments, putting the athlete at risk of 
injury every time he or she uses that muscle and puts strain on its connective tissue 
82
. 
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 Due to the concern of the side effects above many associations in the U.S. such as 
the Recombinant DNA Advisory Committee (RAC) will not approve genetic 
modification aimed at anything but treatment 
83
. Countries around the world, such as the 
United States, have enacted strict requirements for genetic clinical studies, requiring 
approval from the U.S. Food and Drug Administration (FDA), National Institutes of 
Health (NIH), and the RAC before any federal funds are allocated 
84
.  
 These steps, however, might not be enough, as athletes would seek laboratories 
operating illegally in and outside of the US 
85
. The possibility that athletes would turn to 
the black market if gene doping were banned is a very real one as history has shown this 
to be the case with other illicit substances such as drugs and alcohol 
86
. The 
counterargument would be to legalize genetic modification so that it is regulated, leaving 
the athlete to decide whether the pros outweigh the cons 
87
.  
 While athletes engage in risk analysis every time they compete, perhaps the 
consequences of gene doping are currently too unknown for the athlete to make a 
reasoned decision. Likewise, WADA's national affiliates such as the United Kingdom 
Anti-Doping Authority (UKAD) and USADA have echoed WADA's stance and 
introduced campaigns such as "100% me" backed by multi-gold medalist Sir Chris Hoy, 
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and have relentlessly taken down doping "king pins" such as Lance Armstrong in the last 
year 
88
. 
 An additional concern over gene doping would be that its unknown risk/benefit 
analysis would make it impossible for athletes to give informed consent, undermining the 
most basic tenet of medical practice 
89
. Athletes would likely not appreciate the unknown 
risks when weighed against the money and pride associated with winning. This concept is 
known as the Goldman Dilemma, in which elite athletes were asked on a biannual basis 
since the 1980s whether they would take a drug guarantying them Olympic gold if it 
would also kill them within five years 
90
. Over half of the athletes said yes each time the 
survey was conducted 
91
. Similarly, other athletes would feel pressured to make the jump 
and gene dope, as not doing so would put their livelihood at risk 
92
. Many elite athletes, 
particularly from underdeveloped countries, would be faced with the decision to dope and 
remain competitive or work in the mines back home. They justify doping as a way to 
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even the playing field, and that they are not necessarily cheating since they do not have 
an advantage over their competition 
93
. 
 WADA has taken it upon itself to educate athletes, trainers and physicians of the 
dangers of gene doping, specifically in its St. Petersburg Declaration 
94
. One of their 
conclusions was that athletes, trainers, and physicians should be educated so that they can 
critically assess claims on the Internet or elsewhere about the benefits (and detriments) of 
gene doping 
95
. Their stance reflects the current unknown consequences of gene doping 
and the impossibility of obtaining informed consent without better knowing the 
associated risks 
96
. Yet, there is a possibility that after adequate testing gene doping could 
be safe and/or the risk would be quantifiable. Arguably, this would undermine WADA’s 
primary justification of the athlete’s safety and shift the argument to fair play 97. 
 In all, the IOC, WADA, USADA, UKAD, and other organizations under this 
umbrella share the same policy stance about genetics; that gene therapy is a promising 
technology that can be abused by athletes as a form of doping 
98
. While there are no gene 
doping tests currently in practice, the mentioned organizations have been working 
steadfastly to come up with one by the next Olympics 
99
. That being said, there has been 
speculation over certain Chinese swimmers who performed way beyond their previous 
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results at London 2012, as well as reports of Chinese hospitals offering gene therapies to 
anyone willing to pay their price, but until a test is developed this can only be speculation 
100
. Still, the increase in media coverage on the topic has shown just how imminent gene 
doping is. 
 
IV. How Should WADA Regulate Gene Doping? 
 As mentioned in the introduction, it is unclear whether gene doping should be 
treated like pharmaceutical doping or as a technological innovation. Even if gene doping 
is treated like anabolic steroid use and is completely banned, there would be problems in 
applying the black and white approach of doping sanctions in the gray area of gene 
modification. For one, the permanency of gene modification would impose a lifelong ban 
on an athlete, running at odds with WADA's constitutional approach of granting second 
chances 
101
. While there are many similarities between traditional pharmaceutical doping 
and gene doping, there are just as many similarities between gene doping and non-genetic 
technological innovation in sport. Cyclists benefit from the latest aerodynamic equipment 
to help them reduce drag, ski-jumpers benefit from the latest skin suits to help them hold 
flight in the air, swimmers benefitted from slippery swimsuits, and disabled runners 
benefit from the latest prosthetic legs so much so that their competitors claim the 
prosthetics are faster than real legs 
102
. 
 The primary difference between pharmaceutical doping and gene doping is that in 
gene doping genetic material is introduced and assimilated into the body where as in 
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traditional forms of doping, the substance stimulates growth in the body and the 
development of new cells temporarily. The distinction is that pharmaceutical doping 
actively stimulates change in the body that is excreted for a limited time, where as genetic 
material has to be assimilated by the body, which then expresses the desired changes, 
based on the new genetic code going forward. While this may seem to be a very narrow 
distinction, it might make all the difference when one compares gene doping to high 
altitude training.  
 In altitude training the lack of oxygen in the air forces the body to adapt and 
produce more red blood cells so that it becomes more efficient at absorbing the scarce 
oxygen 
103
. Further, there are altitude chambers readily available for purchase that allow 
athletes to reduce the density of air while they sleep at night, without ever having to step 
foot on a mountain 
104
. In 2006, WADA decided not to ban altitude chambers because 
their biological response came only as a result of informational input (i.e. lower oxygen 
content) instead of a pharmaceutical reaction 
105
. Thus, the similarity between gene 
doping and altitude training is that the input forces the body to adapt and modify its 
output, which is distinguishable from pharmaceutical doping, which artificially trumps 
the DNA and stimulates the body to produce more output without a biological response 
106
.   
 Commentators such as Coleman have pointed out that while steroids push the 
body to grow more and produce more tissue, genetic material “cannot cause the body to 
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be more and perform differently that its genes would otherwise allow” 107. In essence, the 
performance benefits of gene doping are the products of the athlete’s own body, albeit 
enhanced. Yet, Coleman’s conclusions raise questions on what constitutes a person’s 
DNA, particularly when a genetic transfer becomes the athletes own permanent DNA. 
Does a person who undergoes gene therapy ever get to claim ownership of their DNA, or 
do they forever carry the stigma (i.e. plastic surgery, Botox, silicone implants) of being 
genetically enhanced? In the context of genetic transfer, perhaps sporting bodies would 
debate whether only the athlete’s DNA at birth is his or her own DNA, despite the 
permanency genetic transfer would have on the athlete’s actual DNA. This debate could 
go either way, indicating that current anti-doping measures would be inadequate at 
dealing with genetic doping since it raises too many questions and too closely resembles 
natural adaptations. 
 If and when gene doping becomes widespread, doping authorities will be faced 
with many challenges such as the difficulty of detection through blood work or the overly 
expensive and intrusive nature of muscle biopsy. Yet, if authorities develop an 
inexpensive, unobtrusive, and effective means of catching gene dopers, they would still 
run into difficulty distinguishing between cheaters and those like Finnish skier Eero 
Mantyranta who was born with a genetic mutation 
108
.  
 Once genetic material is introduced to the body, there is no way of removing or 
muting that material, meaning that the change is permanent. The dilemma is that such a 
genetically modified athlete would have to be banned for life since they would always be 
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genetically enhanced 
109
. While the risk of a lifetime ban is the athlete’s, this one-and-
done ban runs against WADA’s policies, which allow for athletes to come clean and have 
a second chance 
110. WADA’s policy explicitly mandates a two-year suspension for first 
time offenders, yet under their current zero-tolerance policy, the two-year suspension 
would last indefinitely since genetic change is permanent 
111
.  
 WADA's constitutional conflict would mean that even an athlete who admits to 
having done wrong by gene doping could not be given a second chance since that athlete 
will forever be genetic enhanced! Currently, a number of reformed cyclists are serving as 
anti-doping ambassadors in the sport; a fair tradeoff for athletes deserving a second 
chance 
112
. Yet, without having such an opportunity, gene dopers would be quickly 
forgotten and their competitors would just as quickly forget about the consequences of 
gene doping. This disparate treatment would be even more pronounced if two athletes 
were caught for using EPO, one pharmaceutical and the other genetic. After two years, 
the pharmaceutical doper would be cleared to compete, but the genetic doper cannot since 
it is known that his condition is permanent. Perhaps the only way for the gene doper to 
compete again would be to undergo a reversing treatment (if one were possible) and then 
be tested for reinstatement.  
 Moreover, athletes, just like all other people should have access to therapeutic 
gene uses (as opposed to enhancements) when they become medically available 
113
. 
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WADA’s Code provides for “therapeutic use exemptions” when treatment requires the 
legitimate use of drugs not permitted in competition 
114
. Under traditional therapeutic 
treatment, athletes can return to competition free of any sanctions once the procedure is 
completed 
115
. The moral dilemma comes up when at an early age a child undergoes 
therapeutic gene modification and later wishes to compete at the elite level 
116
. Does 
WADA then ban the athlete for having a necessary procedure, or recognize its legitimacy 
and allow the athlete to compete with a distinct advantage 
117
? Further, what if a famous 
athlete is diagnosed with cancer and the only means of treatment is genetic modification 
using EPO. Would sporting bodies make an exception to allow the athlete to compete, 
and would competitors feel such an exception was fair? 
 Bans on genetic modification could run opposed to human rights standards under 
the Universal Declaration on the Human Genome and Human Rights 
118
. Article 2 states 
that “everyone has a right to respect for their dignity and for their rights regardless of 
their genetic characteristics,” and Article 6 states “no one shall be subjected to 
discrimination based on genetic characteristics that are intended to infringe or have the 
effect of infringing human rights” 119. Indeed, this would be a difficult decision for 
WADA to make because neither of the two outcomes, banning the athlete or letting the 
athlete complete, would be fair. Hence, the anti-doping authorities need to rethink their 
policies and provide for an alternative means of dealing with genetically modified 
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athletes, particularly when such athletes had no malicious intent to cheat. I suggest, that 
WADA regulate enhanced athletes by enforcing a measurable handicap appropriate for 
their sport, or putting enhanced athletes in a separate, enhanced category of competition. 
 Obviously, WADA has already passed judgment on genetic modification by 
labeling it “gene doping” and tried to take a stance on the practice before it becomes 
prevalent 
120
. Yet, genetic modification shows promise in the many legitimate benefits it 
could provide to society 
121
. If the medical field and society at large perceive genetic 
modification in the eyes of WADA, perhaps the technology would never realize its full 
potential 
122
.  
 The first step WADA should take is relabeling “gene doping” into a more neutral 
title to remove the negative connotation it receives by being called “doping.” The Code 
can continue to disallow it for now, since the point would be to allow society to make up 
their minds on whether genetic modification is good or bad, without being told by 
WADA and USADA that genetic modification is the equivalent of pharmaceutical 
doping. WADA itself recognized the impact it has on social perceptions in its St. 
Petersburg Declaration, noting that sport is likely one of the first places where genetic 
treatment and enhancement will be debated 
123
. 
 Under the current regime, steroid use is the equivalent to illicit drug use and by 
and large society has taken the stance that illicit drug use is unacceptable 
124
. Entire 
campaigns are focused around dissuading people from taking drugs, not leaving it up to 
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the individual to decide whether or not drugs are good or bad 
125
. If genetic modification 
were also grouped into this category as a result of WADA’s policies, perhaps society 
would dismiss the potential benefits of gene therapy as a deviant practice without even 
giving it a chance 
126
. If genetic modification is given a chance and is found to be 
beneficial to society, WADA’s dismissive stance on the subject would pigeonhole it from 
what society has decided is acceptable 
127
. 
 If and when society decides that genetic modification is acceptable, authorities 
need to decide where to redraw the line. Allowing all forms of genetic modification 
cannot be the solution as the financial and social benefits association with winning a 
competition would pressure all athletes to genetically enhance just to remain competitive. 
WADA and other sporting authorities would have to maintain some level of fairness in 
order to keep both natural and enhanced athletes content. If athletes were completely free 
to gene dope, sport would turn into an arms race of who can purchase better genes, 
making the cost of competition prohibitive to less established athletes. 
 One option would be to disregard how an athlete with abnormal levels of 
hematocrit obtained them (whether it be through pharmaceutical EPO, genetic EPO, or 
genetic mutation) and say that cyclist, runners, and other endurance athletes with more 
than “x” amount of “y” cannot participate in the same category deemed to be natural. 
This could then go in anyone of two ways: either such athletes would have no category to 
compete in, or such athletes would compete in an enhanced category. The name of the 
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enhanced category can be strategic in order to dissuade athletes from the "gene doped" 
category and incentivize remaining clean for the natural category. 
 Another option would be to single out the athletes with abnormal levels of EPO or 
IGF-1 and conduct an investigation on whether such elevated levels are products of 
legitimate therapeutic uses or illegitimate attempts at cheating. At that point athletes 
without a legitimate therapeutic use (i.e. they were dying of cancer) would be banned 
from competition so long as such levels remain abnormally high. This, however, would 
inevitably come to the question of which therapeutic uses are legitimate. Cancer certainly 
would be one, but perhaps other procedures would be mere charades for dopers. While 
this investigatory method would be harsh to athletes like Eero Mantyranta, perhaps the 
level playing field for all others would make up for it. On that note, if the Mantyrantas of 
the world wanted to compete, they might (emphasis on might) be able to genetically 
diminish their EPO levels.  
 A final option would be allow those athletes to compete side by side natural 
athletes, but to attach some quantifiable “handicap” to their performance such as having 
them run 27 mile marathons (instead of 26.2) or having them sprint 110 meters (instead 
of 100).  The difficulty here would be coming up with what handicap would exactly 
compensate for a gene doper's genetic advantage. Racer are won or lost by hundredths of 
a second, and thus, every inch would matter. 
 While quantifiable handicaps might not translate well in all sports, it is at least 
another available option to deal with genetic modification. In fact, many amateur level 
cycling races make use of racing handicaps to deal with varying levels of skill and 
experience. For example, in order for a race promoter to break even, the promoter might 
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allow Cat.3 (low category) cyclist to compete with Pro, Cat.1 (high), and Cat.2 
(intermediate) cyclist. While the Cat.3’s would be at a distinct disadvantage, the promoter 
might attempt to level the playing field by starting the Cat.3’s with a two-minute 
advantage 
128
. Similarly, other sports such as boxing, wrestling, and rowing have weight 
categories to accommodate athletes that cannot compete against competition with a 
distinct (but natural) size advantage 
129
. Finally, athletic competition is already divided 
among lines of gender because it is believed that intermingling competition would be 
unfair to one or both genders 
130
. Yet, there are instances where female athletes that 
outperform their competition are allowed to compete against males 
131
. In rowing, female 
coxswains are free to compete in both male and female events since it is their 
nonphysical skills (motivating rowers and steering the boat) that set them apart. Still, 
instances of males competing in female sports are nearly unheard of, save a few 
transgender cases 
132
. 
 These alternative methods do of course have some limitations. For example, 
creating distinct categories for enhanced athletes might not be as easy as it sounds since it 
would require sporting bodies to handle the logistics of another race, game, league and so 
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on. Creating a separate category might be a financial nightmare particularly if it 
consumes a lot of the promoter’s time for only a few athletes that compete at the 
enhanced level. Further, if athletes find the enhanced level to be more lucrative than their 
present level, this might unnecessarily pressure them into genetic enhancement. The other 
side of this argument is that if there is no league for enhanced athletes, they have 
nowhere to compete and could be faced with the decision to forgo necessary genetic 
treatment in order to compete. 
 Another limitation would be how to effectively categorize the athletes. To say that 
the only relevant trait in cycling is your hematocrit level would be to severely undermine 
all other factors such as training, motivation, and skill. Similarly, to say that IGF-1 is the 
only relevant factor in weightlifting would be to eliminate all other means that athletes 
could use to cheat. If sporting bodies only tested EPO or IGF-1 then athletes would look 
for other means to avoid the enhanced category. Ultimately, if sporting bodies were 
concerned for their athletes’ health, they would find a way to allow for genetic 
modification in a controlled manner because its outright ban simply forces people to the 
black market.  
 On the other hand, sports could play a vital role in developing genetic therapies, 
as the medical field might race to catch a portion of the market share. For example, Dr. 
Dello Russo is one of a handful of doctors that pioneered lasik surgery in the 1990s, and 
has local professional teams such as the NY Giants and Brooklyn Nets endorse his 
procedure 
133. The public, at large, recognizes that a football and basketball player’s 
vision is crucial to his or her success and would think that if such athlete used the 
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procedure then they would try it too. As a result, Dr. Dello Russo is known as the leading 
lasik surgeon in the area, if not the country, and has captured a large portion of the 
market for lasik 
134
. 
 Traditionalists would likely argue that allowing any form of genetic modification 
in sports would defeat the romantic ideal of sport as the spirit’s triumph over body and 
result in competition that is so unreal that sports would become a spectacle 
135
. 
Friedmann explains,  
 
“what are the endpoints of manipulation?..  How fully can 
we engineer the human body… something that looks like a 
human, but is so engineered, that it’s no longer going to do 
what the body is designed to do” 136?  
 
 
Others would argue that the very nature of sport is incrementally getting stronger, better, 
faster. Currently, it's clear what field WADA stands in, yet, this traditionalist approach 
does not necessarily reflect society’s stance since it has not yet had a chance to judge 137. 
Ideally, WADA will find a way to balance its priorities of fair play and athletes' health 
with the game changing reality that genetic modification will be. 
 
V. Conclusion  
 At this point in the debate, it is hard to say which method of dealing with gene 
doping is best, or that certain options are superior to others as all have their own pros and 
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cons. The point is simply to open the discussion and have athletes, sporting bodies, and 
society at large take a clean look at “gene doping” and decide how they want to proceed.  
 Personally, I believe that if genetic modification develops into a legitimate 
practice, then sporting bodies should not interfere by smudging it as "doping" for the sake 
of maintaining their integrity. WADA has the opportunity to play an instrumental role in 
the development of genetic modification by neutralizing its stance on “gene doping” and 
collaborating with the scientific and medical communities to monitor the development of 
genetic therapies. By labeling genetic modification "gene doping" it has already burnt 
bridges in a potential enterprise to enrich both everyday people and elite athletes. 
 Further, I feel strongly against prohibiting athletes from competing for whatever 
reason, whether they doped or were treated for disease via genetic transfer. Thus, I feel 
that sporting organization should accommodate all athletes by finding a fair way for them 
to compete either in separate enhanced leagues, or natural leagues with a handicap. I 
believe strongly in dissuading athletes from cheating, yet I feel equally as strong about 
giving repentant athletes a second chance. 
 Finally, WADA’s role will inevitably shape the public’s view of how such gene 
therapies are perceived, and so they will have to be particularly careful of where to draw 
the line in order to not discourage the development of genetic therapies while also 
preserving the integrity of their organization and sport as a whole. The future leaves us 
with many Superbowls, Tours de France, and Olympics ahead, and one can only wait to 
see how genetic modification is received. 
